Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome

Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome

Aim. To conduct a comparative analysis of the effect of long-term pharmacotherapy (12 months) using a β-blocker (nebivolol) and its combination with eplerenone in patients after ST-segment elevation acute coronary syndrome (STE-ACS) with heart failure with mildly reduced ejection fraction (EF) (HFmr...

Full description

Bibliographic Details
Main Authors: O. A. Osipova, V. P. Mikhin, A. I. Golovin, O. N. Belousova, D. N. Perutsky, P. K. Alferov, S. L. Konstantinov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2022-07-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
острый коронарный синдром с подъемом сегмента st
сердечная недостаточность с умеренно низкой фракцией выброса левого желудочка
небиволол
эплеренон
антагонист минералокортикоидных рецепторов
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3269

Internet

https://cardiovascular.elpub.ru/jour/article/view/3269

Similar Items